Medtech

UFP Technologies Announces Record 2023 Results

Retrieved on: 
Wednesday, February 21, 2024

Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million.

Key Points: 
  • Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million.
  • Sales for the fourth quarter 2023 were $101.5 million, 11.2% higher than 2022 fourth quarter sales of $91.2 million.
  • “I am very pleased with our fourth quarter and full year 2023 results,” said R. Jeffrey Bailly, Chairman & CEO.
  • Full year 2023 adjusted operating income increased 37.9% to $61.3 million, from $44.5 million in the same period of 2022.

U.S. Physical Therapy to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Friday, March 8, 2024

U.S.

Key Points: 
  • U.S.
  • Physical Therapy, Inc. (NYSE: USPH) (the “Company”), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Carey Hendrickson, Chief Financial Officer, will present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on Tuesday, March 12, 2024.
  • The presentation will cover an overview of the Company.

KARL STORZ Launches CollaboratOR 3D for Apple Vision Pro

Retrieved on: 
Thursday, March 7, 2024

Pioneering MedTech company KARL STORZ is proud to announce the release of the CollaboratOR 3D app for Apple Vision Pro.

Key Points: 
  • Pioneering MedTech company KARL STORZ is proud to announce the release of the CollaboratOR 3D app for Apple Vision Pro.
  • View the full release here: https://www.businesswire.com/news/home/20240307439295/en/
    With the CollaboratOR 3D app for Apple Vision Pro, surgical staff can immerse themselves in 3D content from surgical procedures—without even entering the operating room.
  • With the CollaboratOR 3D app for Apple Vision Pro, surgical staff can immerse themselves in 3D content from surgical procedures—without even entering the operating room.
  • “The release of the CollaboratOR 3D app for Apple Vision Pro aligns with our long-term vision to apply tomorrow’s technology to today’s most pressing healthcare needs.

Fierce Medtech Names Genesis Therapeutics a “Fierce 15” Company of 2023

Retrieved on: 
Wednesday, March 6, 2024

Genesis Therapeutics , a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved patient populations, today announced that Fierce Medtech has named it as one of 2023’s “Fierce 15” medtech companies.

Key Points: 
  • Genesis Therapeutics , a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved patient populations, today announced that Fierce Medtech has named it as one of 2023’s “Fierce 15” medtech companies.
  • "We are honored to receive this recognition from Fierce and be included among true innovators in AI and life sciences," said Evan Feinberg, Ph.D., co-founder and CEO of Genesis.
  • Being named a Fierce 15 company is testament that our team is yielding tangible results in developing AI technologies that generate transformative drugs for patients."
  • “These companies exemplify the ability of the life sciences industry to turn cutting-edge ideas into meaningful outcomes.”

STAAR Surgical to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Wednesday, March 6, 2024

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following conferences:

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following conferences:
    Oppenheimer Healthcare MedTech & Services Conference, Tuesday, March 12
    Management will also meet with investors in Shenzhen and Shanghai, China, from Monday, March 18 through Wednesday, March 20.
  • Investor participation is by invitation from each sponsoring brokerage firm.

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

Retrieved on: 
Wednesday, March 6, 2024

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Oppenheimer Healthcare MedTech & Services Conference, being held virtually.

Key Points: 
  • Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Oppenheimer Healthcare MedTech & Services Conference, being held virtually.
  • Management is scheduled to participate on Wednesday, March 13, 2024, at 12:00pm ET and will hold one-on-one meetings following.
  • Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com .

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

Retrieved on: 
Wednesday, March 6, 2024

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 34th Annual Virtual Healthcare MedTech & Services Conference at 12:40 p.m.

Key Points: 
  • AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 34th Annual Virtual Healthcare MedTech & Services Conference at 12:40 p.m.
  • ET on Tuesday, March 12, 2024.
  • A live webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.

Butterfly Network to Participate at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Wednesday, March 6, 2024

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executive Vice President, Chief Financial and Operations Officer, will participate in a fireside chat and host one-on-one investor meetings at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 13, 2024, at 8:40 am ET.
  • The conference will be held virtually.
  • A webcast of the fireside chat will be available in the Events & Presentations section of the Butterfly investor website, and available for replay following the event until June 11, 2024.
  • To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.

Aktana Announces Release of Next Generation Omnichannel Orchestration Tools Designed for Medical Technology Companies

Retrieved on: 
Tuesday, March 5, 2024

“However, less than 20% of MedTech companies are using advanced omnichannel capabilities.

Key Points: 
  • “However, less than 20% of MedTech companies are using advanced omnichannel capabilities.
  • Aktana for MedTech is comprised of Aktana’s world-class open platform, Field Orchestrator, Omnichannel Orchestrator, Analytics Activator, as well as Copilot Mobile.
  • Specifically, Aktana for MedTech:
    Allows medical technology companies to simplify scheduling, manage stock, optimize inventory utilization and streamline procurement processes with AI-powered omnichannel orchestration.
  • Today, commercial and medical teams from more than 350 brands use Aktana’s next generation-AI complete orchestration to deliver personalized omnichannel engagement at scale.

Addus HomeCare to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Tuesday, March 5, 2024

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman, President and Brad Bickham, President and Chief Operating Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 12, 2024.

Key Points: 
  • Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman, President and Brad Bickham, President and Chief Operating Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 12, 2024.
  • In connection with the virtual conference, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com , starting at 11:20 a.m. Eastern Time / 10:20 a.m. Central Time on Tuesday, March 12, 2024.
  • An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.